Cargando…

Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies

BACKGROUND: Asthma and diabetes are both diseases that affect a wide range of people worldwide. As a common treatment for diabetes, metformin has also been reported to be effective in improving asthma outcomes. We conducted a combined analysis to examine the efficacy of metformin in reducing asthma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Li, Zhong, Wang, Chai, Yihui, Zhong, Qin, Gao, Jie, Guan, Liancheng, Zhang mengzhi, Huaiquan, Liu, Haiyang, Yu, Qingxue, Wang, Changfu, Yang, Yunzhi, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424499/
https://www.ncbi.nlm.nih.gov/pubmed/32831980
http://dx.doi.org/10.1155/2020/9705604
_version_ 1783570351783936000
author Wen, Li
Zhong, Wang
Chai, Yihui
Zhong, Qin
Gao, Jie
Guan, Liancheng
Zhang mengzhi,
Huaiquan, Liu
Haiyang, Yu
Qingxue, Wang
Changfu, Yang
Yunzhi, Chen
author_facet Wen, Li
Zhong, Wang
Chai, Yihui
Zhong, Qin
Gao, Jie
Guan, Liancheng
Zhang mengzhi,
Huaiquan, Liu
Haiyang, Yu
Qingxue, Wang
Changfu, Yang
Yunzhi, Chen
author_sort Wen, Li
collection PubMed
description BACKGROUND: Asthma and diabetes are both diseases that affect a wide range of people worldwide. As a common treatment for diabetes, metformin has also been reported to be effective in improving asthma outcomes. We conducted a combined analysis to examine the efficacy of metformin in reducing asthma exacerbation in patients with concurrent asthma and diabetes. METHODS: We searched the PubMed, Embase, and CENTRAL databases for articles published prior to April 2020 to find observational studies of individuals with concurrent asthma and diabetes that compared the risk of asthma exacerbation between metformin users and nonusers. Two researchers separately screened the studies, extracted data, and evaluated the risk of bias. The primary outcome was the adjusted risk of asthma exacerbation. The secondary outcomes were the adjusted risk of asthma-related hospitalization and emergency room visits. Review Manager was used for data analysis and plotting. I(2) and χ(2) tests were used to estimate heterogeneity. A random effects or fixed effects model was used depending on the heterogeneity. Odds ratios were calculated for dichotomous variables. RESULTS: We included two studies with a total of 25252 patients. The pooled effect size showed that metformin was inversely associated with a risk of asthma exacerbation (OR = 0.65, 95% CI 0.28–1.48; χ(2) = 5.42, P=0.02; I(2) = 82%), asthma-related emergency department visits (OR = 0.81, 95% CI 0.74–0.89; χ(2) = 0.36, P=0.55; I(2) = 0%), and hospitalizations (OR = 0.43, 95% CI 0.14–1.29; χ(2) = 4.01, P=0.05; I(2) = 75%). CONCLUSION: This meta-analysis suggested that metformin decreased the risk of asthma-related emergency room visits for patients with concurrent asthma and diabetes. Metformin reduced the risk of asthma-related hospitalization and exacerbation but was not statistically significant. More randomized trials involving larger samples should be considered, and the mechanisms of these effects need to be fully elucidated.
format Online
Article
Text
id pubmed-7424499
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74244992020-08-20 Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies Wen, Li Zhong, Wang Chai, Yihui Zhong, Qin Gao, Jie Guan, Liancheng Zhang mengzhi, Huaiquan, Liu Haiyang, Yu Qingxue, Wang Changfu, Yang Yunzhi, Chen Can Respir J Review Article BACKGROUND: Asthma and diabetes are both diseases that affect a wide range of people worldwide. As a common treatment for diabetes, metformin has also been reported to be effective in improving asthma outcomes. We conducted a combined analysis to examine the efficacy of metformin in reducing asthma exacerbation in patients with concurrent asthma and diabetes. METHODS: We searched the PubMed, Embase, and CENTRAL databases for articles published prior to April 2020 to find observational studies of individuals with concurrent asthma and diabetes that compared the risk of asthma exacerbation between metformin users and nonusers. Two researchers separately screened the studies, extracted data, and evaluated the risk of bias. The primary outcome was the adjusted risk of asthma exacerbation. The secondary outcomes were the adjusted risk of asthma-related hospitalization and emergency room visits. Review Manager was used for data analysis and plotting. I(2) and χ(2) tests were used to estimate heterogeneity. A random effects or fixed effects model was used depending on the heterogeneity. Odds ratios were calculated for dichotomous variables. RESULTS: We included two studies with a total of 25252 patients. The pooled effect size showed that metformin was inversely associated with a risk of asthma exacerbation (OR = 0.65, 95% CI 0.28–1.48; χ(2) = 5.42, P=0.02; I(2) = 82%), asthma-related emergency department visits (OR = 0.81, 95% CI 0.74–0.89; χ(2) = 0.36, P=0.55; I(2) = 0%), and hospitalizations (OR = 0.43, 95% CI 0.14–1.29; χ(2) = 4.01, P=0.05; I(2) = 75%). CONCLUSION: This meta-analysis suggested that metformin decreased the risk of asthma-related emergency room visits for patients with concurrent asthma and diabetes. Metformin reduced the risk of asthma-related hospitalization and exacerbation but was not statistically significant. More randomized trials involving larger samples should be considered, and the mechanisms of these effects need to be fully elucidated. Hindawi 2020-08-04 /pmc/articles/PMC7424499/ /pubmed/32831980 http://dx.doi.org/10.1155/2020/9705604 Text en Copyright © 2020 Li Wen et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Wen, Li
Zhong, Wang
Chai, Yihui
Zhong, Qin
Gao, Jie
Guan, Liancheng
Zhang mengzhi,
Huaiquan, Liu
Haiyang, Yu
Qingxue, Wang
Changfu, Yang
Yunzhi, Chen
Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies
title Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies
title_full Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies
title_fullStr Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies
title_full_unstemmed Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies
title_short Association of Metformin Use with Asthma Exacerbation in Patients with Concurrent Asthma and Diabetes: A Systematic Review and Meta-Analysis of Observational Studies
title_sort association of metformin use with asthma exacerbation in patients with concurrent asthma and diabetes: a systematic review and meta-analysis of observational studies
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424499/
https://www.ncbi.nlm.nih.gov/pubmed/32831980
http://dx.doi.org/10.1155/2020/9705604
work_keys_str_mv AT wenli associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT zhongwang associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT chaiyihui associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT zhongqin associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT gaojie associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT guanliancheng associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT zhangmengzhi associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT huaiquanliu associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT haiyangyu associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT qingxuewang associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT changfuyang associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies
AT yunzhichen associationofmetforminusewithasthmaexacerbationinpatientswithconcurrentasthmaanddiabetesasystematicreviewandmetaanalysisofobservationalstudies